Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Electrocore Inc (ECOR)

Electrocore Inc (ECOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ecora Resources PLC Announces Q2 2023 Trading Update ACCESSWIRE - Tue Jul 25, 2023

Ecora Resources PLC ("Ecora", the "Group" or the "Company") Q2 2023 Trading Update

ECOR : 5.74 (+2.14%)
ECOR.LN : 78.850 (-3.37%)
ECOR.TO : 1.35 (-5.59%)
ECRAF : 1.0044 (-2.01%)
electroCore and Joerns Healthcare Partner to Expand Use Of gammaCore™ Vagus Nerve Technology for Headache Sufferers PR Newswire - Tue Nov 1, 2022

/PRNewswire/ -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage, bioelectronic medicine company, announced today that gammaCore Sapphire™, the first and...

ECOR : 5.74 (+2.14%)
electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference Globe Newswire - Fri Aug 5, 2022

ROCKAWAY, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced...

ECOR : 5.74 (+2.14%)
electroCore to Announce Second Quarter 2022 Financial Results on August 4 Globe Newswire - Thu Jul 28, 2022

ROCKAWAY, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today...

ECOR : 5.74 (+2.14%)
electroCore Provides Select Second Quarter 2022 Financial Guidance Globe Newswire - Tue Jul 12, 2022

Record revenue will be at least $2.1 million; approximately 65% growth over second quarter 2021June 30, 2022, cash and cash equivalents balance of...

ECOR : 5.74 (+2.14%)
electroCore, Inc. Announces Study of gammaCore Sapphire™ for the Treatment of Post-COVID Syndrome Globe Newswire - Thu Jul 7, 2022

ROCKAWAY, N.J., July 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today...

ECOR : 5.74 (+2.14%)
electroCore, Inc. Announces gammaCore™ Non-Invasive Vagus Nerve Stimulator Available Through National Spine and Pain Centers Globe Newswire - Tue May 24, 2022

ROCKAWAY, N.J., May 24, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced...

ECOR : 5.74 (+2.14%)
electroCore to Participate at Upcoming Investor Conferences Globe Newswire - Wed May 18, 2022

ROCKAWAY, N.J., May 18, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced...

ECOR : 5.74 (+2.14%)
electroCore Announces Record First Quarter 2022 Financial Results Globe Newswire - Thu May 5, 2022

First quarter 2022 net sales of $1.9 million, approximately 58% over first quarter 2021 and 27% sequentially Company to host a conference call and webcast...

ECOR : 5.74 (+2.14%)
electroCore Completes Sale of New Jersey Tax Benefits Globe Newswire - Tue Apr 26, 2022

ROCKAWAY, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced...

ECOR : 5.74 (+2.14%)

Barchart Exclusives

Bottom 100 Stocks to Buy: Very Aggressive Investors Might Consider a Small Wager on This Class Action Stock Barchart - 58 minutes ago
Sonder Holdings faces a potential class action lawsuit over the handling of its financial statements in 2022 and 2023. The penny stock has lost nearly 60% of its value over the past year and is in Barchart’s Bottom 100 Stocks to Buy. Yet, it could be a moneymaker for aggressive investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot